W Dong, J Zhong, Y Chen, J Xie, Y Qin,
J Xu… - Acta Pharmacologica …, 2021 - nature.com
We have previously shown that roflupram (ROF) protects against MPP+-induced neuronal
damage in models of Parkinson's disease (PD). Since impaired degradation of α-synuclein …